# A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

> **NCT02640807** · PHASE2 · COMPLETED · sponsor: **Revimmune** · enrollment: 27 (actual)

## Conditions studied

- Severe Sepsis With Septic Shock

## Interventions

- **DRUG:** Interleukin-7
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02640807
- **Lead sponsor:** Revimmune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-08-27
- **Final completion:** 2018-08-27
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-07-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02640807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02640807, "A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02640807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*